Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Terbuch Angelika |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Moik, F; Terbuch, A; Sprakel, A; Pichler, G; Barth, DA; Pichler, R; Rainer, P; Silbernagel, G; Mannweiler, S; Jost, PJ; Ahyai, SA; Bauernhofer, T; Hutterer, GC; Pichler, M Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
J Thromb Haemost. 2025; Doi: 10.1016/j.jtha.2025.01.022
PubMed FullText FullText_MUG

 

** Theiler-Schwetz, V; Trummer, C; Schmitt, L; Terbuch, A; Obermayer-Pietsch, B; Richtig, E; Pilz, S High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial.
Ann Med. 2025; 57(1): 2453829 Doi: 10.1080/07853890.2025.2453829 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2024

Full paper/article (Journal)

** Antonelli, L; Heidenreich, A; Bagrodia, A; Amini, A; Baky, F; Branger, N; Cazzaniga, W; Clinton, TN; Daneshmand, S; Djaladat, H; Eggener, S; Ghoreifi, A; Hamilton, RJ; Ho, M; Sexton, WJ; Nazzani, S; Nicol, D; Nicolai, N; Olson, K; Paffenholz, P; Porter, J; Qian, Z; Rocco, NR; Yerrapragada, A; Stroup, SP; Tachibana, I; Terbuch, A; Singla, N; Cary, C; Fankhauser, CD, , EAU‐YAU, Penile, and, Testis, Cancer, Working, Group Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
BJU Int. 2024; Doi: 10.1111/bju.16618
Web of Science PubMed FullText FullText_MUG

 

** Bührer, E; D'Haese, D; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Collette, L; Gillessen, S; Beyer, J Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Eur J Cancer. 2024; 202:114042 Doi: 10.1016/j.ejca.2024.114042
Web of Science PubMed FullText FullText_MUG

 

** Fischer, S; Gillessen, S; Stalder, O; Terbuch, A; Cathomas, R; Schmid, FA; Zihler, D; Müller, B; Fankhauser, CD; Hirschi-Blickenstorfer, A; Kluth, LA; Seifert, B; Templeton, AJ; Mingrone, W; Ufe, MP; Fischer, N; Beyer, J; Woelky, R; Omlin, A; Vogl, U; Hoppe, K; Kamradt, J; Rothschild, SI; Rothermundt, C First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Eur Urol Open Sci. 2024; 68: 68-74. Doi: 10.1016/j.euros.2024.08.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hochmair, M; Terbuch, A; Lang, D; Trockenbacher, C; Augustin, F; Ghanim, B; Maurer, D; Taghizadeh, H; Kamhuber, C; Wurm, R; Lindenmann, J; Braz, P; Bundalo, T; Begic, M; Bauer, J; Reimann, P; Müser, N; Huemer, F; Schlintl, V; Bianconi, D; Baumgartner, B; Schenk, P; Rauter, M; Hötzenecker, K Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.
Cancers (Basel). 2024; 16(14): Doi: 10.3390/cancers16142586 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** John, N; Schlintl, V; Sassmann, T; Lindenmann, J; Fediuk, M; Wurm, R; Douschan, P; Zacharias, M; Kalson, L; Posch, F; Absenger, G; Brcic, L; Jost, PJ; Terbuch, A Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
J Immunother Cancer. 2024; 12(4): Doi: 10.1136/jitc-2023-008592 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Riedl, JM; Barth, D; Berton, F; Fink, M; Englisch, C; Hoeller, C; Fuereder, T; Ay, L; Pabinger, I; Richtig, E; John, N; Kostmann, SM; Jost, PJ; Gerger, A; Terbuch, A; Preusser, M; Ay, C Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors
JACC-CARDIOONCOL. 2024; 6(6): 965-975. Doi: 10.1016/j.jaccao.2024.09.007 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Konjic, S; Schlintl, V; Absenger, G; Jost, PJ; Lindenmann, J; Swatek, P; John, N; John, T; Wurm, R; Zacharias, M; Posch, F; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Wolf, D; Augustin, F; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Transl Lung Cancer Res. 2024; 13(11): 3096-3105. Doi: 10.21037/tlcr-24-433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zacharias, M; Konjic, S; Kratochwill, N; Absenger, G; Terbuch, A; Jost, PJ; Wurm, R; Lindenmann, J; Kashofer, K; Gollowitsch, F; Gorkiewicz, G; Brcic, L Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology.
Cancers (Basel). 2024; 16(5): 903 Doi: 10.3390/cancers16050903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Antonelli, L; Heidenreich, A; Bagrodia, A; Branger, N; Cazzaniga, W; Clinton, TN; Daneshmand, S; Djaladat, H; Eggener, S; Hamilton, RJ; Ho, M; Sexton, WJ; Nazzani, S; Nicol, D; Nicolai, N; Olson, K; Paffenholz, P; Porter, J; Singla, N; Stroup, SP; Tachibana, ; Terbuch, A; Cary, C; Fankhauser, CD Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study
EUR UROL. Abstracts EAU24. 2024; 85: S722-S723.-39th Annual EAU Congress; APR 5-8, 2024; Paris, FRANCE. [Poster]
Web of Science

 

** Antonelli, L; Heidenreich, A; Bagrodia, A; Branger, N; Clinton, T; Daneshmand, S; Djaladat, H; Hamilton, RJ; Ho, M; Sexton, WJ; Nicol, D; Nicolai, N; Olson, K; Porter, J; Singla, N; Stroup, SP; Terbuch, A; Cary, C; Fankhauser, CD Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour: A multicenter retrospective cohort study.
J CLIN ONCOL. Abstracts. 2024; 42(4_SUPPL):516-516.-ASCO - GU Cancers Symposium; JAN 25-27, 2024; San Francisco, USA. Doi: 10.1200/JCO.2024.42.4_suppl.516 [Poster]
Web of Science FullText FullText_MUG

 

** Hamid, A; Huang, JM; Zhong, CW; Xie, WL; Rothmann, E; Nicholls, P; Walk, N; Brcic, I; Terbuch, A; Van Allen, EM; Sweeney, C Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
J CLIN ONCOL. 2024; 42(4_SUPPL):523-523.Jan 25 -27. 2024; San Francisco. Doi: 10.1200/JCO.2024.42.4_suppl.523 [Poster]
Web of Science FullText FullText_MUG

 

** Hochmair, M; Terbuch, A; Lang, D; Trockenbacher, C; Augustin, F; Ghanim, B; Maurer, D; Taghizadeh, H; Kamhuber, C; Wurm, R; Lindenmann, J; Braz, P; Bundalo, T; Begic, M; Bauer, J; Reimann, P; Müser, N; Huemer, F; Schintl, V; Bianconi, D; Baumgartner, B; Schenk, P; Rauter, M; Hötzenecker, K Real-world characteristics and treatment patterns of patients with early-stage non-small cell lung cancer in Austria: the PRATER retrospective study
WIEN KLIN WOCHENSCHR. 2024; 136: S530-S531. [Poster]
Web of Science FullText

 

** John, N; Terbuch, A; Konjic, S; Absenger, G; Jost, PJ; Lindenmann, J; Fediuk, M; Sassmann, T; Wurm, R; Zacharias, M; Posch, F; Hochmaier, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Pircher, A; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer
WIEN KLIN WOCHENSCHR. 2024; 136(S13):S531-S531.-48. Jahrestagung ÖGP - 8th Jahrestagung OGTC; SEP 26-28, 2024; Vienna, Austria. [Poster]
Web of Science

 

2023

Full paper/article (Journal)

** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12): Doi: 10.1136/jitc-2023-007765 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fankhauser, CD; Jandari, A; Collette, L; Tandstad, T; Jiang, DM; De, Giorgi, U; Sweeney, C; Terbuch, A; Chovanec, M; Huddart, R; Bokemeyer, C; Beyer, J; Gillessen, S Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma.
Eur Urol Open Sci. 2023; 56:25-28 Doi: 10.1016/j.euros.2023.08.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fischer, S; Rothermundt, C; Stalder, O; Terbuch, A; Hermanns, T; Zihler, D; Müller, B; Fankhauser, CD; Hirschi-Blickenstorfer, A; Seifert, B; Kluth, LA; Ufe, MP; Mingrone, W; Templeton, AJ; Fischer, N; Rothschild, S; Woelky, R; Gillessen, S; Cathomas, R The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Eur Urol Open Sci. 2023; 50: 57-60. Doi: 10.1016/j.euros.2023.01.013 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch, D; Pichler, M Symptom clusters associated with complementary and alternative medicine use by cancer patients: A cross-sectional study.
PLoS One. 2023; 18(12): e0294641 Doi: 10.1371/journal.pone.0294641 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lauritsen, J; Sauvé, N; Tryakin, A; Jiang, DM; Huddart, R; Heng, DYC; Terbuch, A; Winquist, E; Chovanec, M; Hentrich, M; Fankhauser, CD; Shamash, J; Del, Muro, XG; Vaughn, D; Heidenreich, A; Sternberg, CN; Sweeney, C; Necchi, A; Bokemeyer, C; Bandak, M; Jandari, A; Collette, L; Gillessen, S; Beyer, J; Daugaard, G Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Br J Cancer. 2023; 129(11):1759-1765 Doi: 10.1038/s41416-023-02443-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN. Doi: 10.1016/j.annonc.2023.09.2917 [Poster]
Web of Science FullText FullText_MUG

 

** Champiat, S; Boyer, MJ; Govindan, R; Paz-Ares, LG; Owonikoko, TK; Borghaei, H; Izumi, H; Steeghs, N; Blackhall, FH; Terbuch, A; Johnson, ML; Yoshida, T; He, K; Zhang, YY; Jones, S; Chen, X; Martinez, P; Hummel, HD Tarlatamab in small cell lung cancer (SCLC): Safety and efficacy analyzed by baseline brain metastasis
J CLIN ONCOL. 2023; 41(16): [Poster]
Web of Science

 

2022

Full paper/article (Journal)

** Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konjić, S; Valipour, A Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med. 2022; 11(14): Doi: 10.3390/jcm11144098 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18. Doi: 10.1016/j.euros.2022.03.013 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463 Doi: 10.1038/s41416-021-01601-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832 Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Terbuch, A; Absenger, G Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00828-3
Web of Science FullText FullText_MUG

 

Abstract (Journal)

** Brcic, L; Zacharias, M; Konjic, S; Kashofer, K; Absenger, G; Jost, PJ; Wurm, R; Lindenmann, J; Terbuch, A Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A singlecenter experience
ANN ONCOL. 2022; 38(9): S1557-S1557. Doi: 10.1016/j.annonc.2022.10.344 [Poster]
Web of Science FullText FullText_MUG

 

** Fischer, S; Rothermundt, C; Stalder, O; Terbuch, A; Hermanns, T; Zihler, D; Muller, B; Hirschi-Blickenstorfer, A; Seifert, B; Kluth, LA; Ufe, MP; Mingrone, W; Templeton, A; Fischer, N; Rothschild, S; Beyer, J; Woelky, R; Gillessen, S; Cathomas, R Importance of tumor markers in the detection of recurrences - Findings from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
ONCOL RES TREAT. 2022; 45(SUPPL 2):209-209.-DGHO 2022; [Poster]
Web of Science

 

** Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konji, S; Valipour, A Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
WIEN KLIN WOCHENSCHR. 2022; 134(19-20):727-728.
Web of Science

 

** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322. [Poster]
Web of Science

 

** Villalona-Calero, MA; Patnaik, A; Maki, RG; O'Neil, B; Abbruzzese, JL; Dagogo-Jack, I; Devarakonda, S; Wahlroos, S; Lin, CC; Fujiwara, Y; Terbuch, A; Postel-Vinay, S; Goebeler, ME; Addeo, A; Prenen, H; Arkenau, T; Sacher, AG; Liu, CX; Kormany, W; Ahnert, JR Design and rationale of a phase 1 dose-escalation study of AMG 193, a methylthioadenosine (MTA)-cooperative PRMT5 inhibitor, in patients with advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors
J CLIN ONCOL. 2022; 40(16): [Poster]
Web of Science

 

** Zacharias, M; Konjic, S; Absenger, G; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Jost, PJ; Schlintl, V; Wurm, R; Lindenmann, J; Fediuk, M; Brcic, L; Terbuch, A Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
J THORAC ONCOL. 2022; 17(9): S201-S202. [Poster]
Web of Science

 

** Zgubic, JA; Zacharias, M; Wurm, R; Terbuch, A; Brcic, L Predictive and prognostic relevance of PD-L1 and TIGIT expression in patients with non-small cell lung carcinoma treated with immunotherapy
HISTOPATHOLOGY. 2022; 81: 170-170. [Poster]
Web of Science

 

2021

Full paper/article (Journal)

** Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562 Doi: 10.1200/JCO.20.03292 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400 Doi: 10.1002/1878-0261.12870 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574 Doi: 10.1200/JCO.20.03296 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Yap, TA; Tan, DSP; Terbuch, A; Caldwell, R; Guo, C; Goh, BC; Heong, V; Haris, NRM; Bashir, S; Drew, Y; Hong, DS; Meric-Bernstam, F; Wilkinson, G; Hreiki, J; Wengner, AM; Bladt, F; Schlicker, A; Ludwig, M; Zhou, Y; Liu, L; Bordia, S; Plummer, R; Lagkadinou, E; de Bono, JS First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Cancer Discov. 2021; 11(1):80-91 Doi: 10.1158/2159-8290.CD-20-0868 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zacharias, M; Absenger, G; Kashofer, K; Wurm, R; Lindenmann, J; Terbuch, A; Konjic, S; Sauer, S; Gollowitsch, F; Gorkiewicz, G; Brcic, L Reflex testing in non-small cell lung carcinoma using DNA-and RNA-based next-generation sequencing-a single-center experience
TRANSL LUNG CANCER R. 2021; Doi: 10.21037/tlcr-21-570 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Absenger, G; Terbuch, A Unresectable pleural mesothelioma-hope or still an unmet medical need?
MEMO-MAG EUR MED ONC. 2021; Doi: 10.1007/s12254-021-00727-z
Web of Science FullText FullText_MUG

 

Abstract (Journal)

** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

** Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229. [Poster]
Web of Science

 

2020

Full paper/article (Journal)

** Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331 Doi: 10.1200/JCO.19.01876 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lu, C; Terbuch, A; Dolling, D; Yu, J; Wang, H; Chen, Y; Fountain, J; Bertan, C; Sharp, A; Carreira, S; Isaacs, WB; Antonarakis, ES; De Bono, JS; Luo, J Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype.
Ann Oncol. 2020; 31(9):1178-1185 Doi: 10.1016/j.annonc.2020.04.473
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438. Doi: 10.1038/s41598-020-69237-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Tiu, C; Candilejo, IM; Scaranti, M; Curcean, A; Bar, D; Estevez Timon, M; Ameratunga, M; Ang, JE; Ratoff, J; Minchom, AR; Banerji, U; de Bono, JS; Tunariu, N; Lopez, JS Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.
Clin Cancer Res. 2020; 26(18):4805-4813 Doi: 10.1158/1078-0432.CCR-20-0454
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Lembeck, AL; Puchas, P; Hutterer, G; Barth, DA; Terbuch, A; Bauernhofer, T; Pichler, M MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Noncoding RNA. 2020; 6(1): Doi: 10.3390/ncrna6010002 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Zhou, Q; Graf, R; Klocker, V; Terbuch, A; Dandachi, N; Heitzer, E; Balic, M Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients.
ANN ONCOL. 2020; 31: S41-S41.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.213 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mulder, FI; Candeloro, M; Kamphuisen, PW; Di Nisio, M; Bossuyt, PM; Guman, N; Smit, K; Büller, HR; van Es, N; CAT-prediction collaborators The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Haematologica. 2019; 104(6): 1277-1287. Doi: 10.3324/haematol.2018.209114 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Dandachi, N; Absenger, G; Brcic, L; Kashofer, K; Terbuch, A; Jaritz, L; Stanzer, S; Balic, M Feasibility and clinical value of serial circulating tumor DNA testing in metastatic lung adenocarcinoma patients undergoing TKI treatment
ONCOL RES TREAT. 2019; 42: 213-213. [Poster]
Web of Science

 

** Fischer, SC; Tandstad, T; Cohn-Cedermark, GE; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, MJ; Langberg, CW; Stahl, O; Beyer, J; Gillessen, S Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.
J CLIN ONCOL. 2019; 37(7):-ASCO-GU Genitourinary Cancers Symposium; FEB 15, 2019; San Francisco, CA. Doi: 10.1200/JCO.2019.37.7_suppl.510 [Oral Communication]
Web of Science FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783 Doi: 10.1245/s10434-017-6080-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rothermundt, C; Thurneysen, C; Cathomas, R; Müller, B; Mingrone, W; Hirschi-Blickenstorfer, A; Wehrhahn, T; Ruf, C; Rothschild, S; Seifert, B; Terbuch, A; Grassmugg, T; Woelky, R; Fankhauser, C; Kunit, T; Fischer, NF; Inauen, R; Kamradt, J; Ziegler, K; Haynes, A; Jüni, P; Gillessen, S Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
SWISS MED WKLY. 2018; 148(4): w14640-w14640. Doi: 10.4414/smw.2018.14640 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Terbuch, A; Lopez, J Next Generation Cancer Vaccines-Make It Personal!
Vaccines (Basel). 2018; 6(3): Doi: 10.3390/vaccines6030052 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Proceedings)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

2017

Full paper/article (Journal)

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157 Doi: 10.1016/j.lungcan.2017.10.003
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Herzog, SA; Pichler, M; Smolle, M; Riedl, J; Rossmann, C; Bezan, A; Stöger, H; Renner, W; Berghold, A; Gerger, A Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Anticancer Res. 2017; 37(4):2011-2018 Doi: 10.21873/anticanres.11545 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

2016

Full paper/article (Journal)

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35 Doi: 10.1016/j.juro.2015.01.083
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

Abstract (Journal)

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.513 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.e15617 [Poster]
Web of Science FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Hohla, F; Hopfinger, G; Romeder, F; Rinnerthaler, G; Bezan, A; Stättner, S; Hauser-Kronberger, C; Ulmer, H; Greil, R Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Int J Oncol. 2014; 44(1): 319-26. Doi: 10.3892/ijo.2013.2176 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

2013

Full paper/article (Journal)

** Bezan, A; Hohla, F; Meissnitzer, T; Greil, R Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
BMC Cancer. 2013; 13(1):618-618 Doi: 10.1186/1471-2407-13-618 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint